Laman UtamaDIVISLAB • NSE
add
Divi's Laboratories Ltd
Tutup sebelumnya
₹6,072.50
Julat hari
₹5,988.95 - ₹6,105.85
Julat tahun
₹3,350.00 - ₹6,275.85
Permodalan pasaran
1.60T INR
Bilangan Purata
441.60K
Nisbah P/E
86.81
Hasil dividen
0.50%
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 23.38B | 22.47% |
Perbelanjaan pengendalian | 7.52B | 5.17% |
Pendapatan bersih | 5.10B | 46.55% |
Margin untung bersih | 21.81 | 19.64% |
Pendapatan bagi setiap syer | 19.51 | 48.82% |
EBITDA | 7.15B | 49.58% |
Kadar cukai berkesan | 29.36% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 36.02B | -0.25% |
Jumlah aset | 155.86B | 9.12% |
Jumlah liabiliti | 18.69B | 16.38% |
Jumlah ekuiti | 137.17B | — |
Syer tertunggak | 265.62J | — |
Harga kepada buku | 11.76 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 11.30% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 5.10B | 46.55% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.
In October 2024, Divi and his family were ranked 29th on Forbes list of India’s 100 richest tycoons, with a net worth of $9.2 billion. Wikipedia
Diasaskan
12 Okt 1990
Tapak web
Pekerja
9,741
